Background: Myotonic dystrophy type 1 (DM1; OMIM #160900) is an autosomal-dominant genetic disorder with multisystemic clinical features associated with a CTG expansion in the 3' untranslated region of the DMPK gene on chromosome 19q13.3. A long-PCR protocol to detect the DM1 expansion is rapid, sensitive, and accurate, but interpretative limitations can occur when the expansion size exceeds the PCR amplification range and in cases of somatic mosaicism. Methods: To overcome these problems, we used RNA fluorescence in situ hybridization (RNA-FISH) to study cultured cells derived from chorionic villus samples (CVS) with the DM1 mutation. The RNA-FISH method is designed to detect the distinctive DM1 cellular phenotype, characterized by the presence of nuclei with focal ribonuclear inclusions (foci) containing the DMPK expanded transcripts. We analyzed 6 CVS from DM1-predicted pregnancies and 6 CVS from DM1-negative pregnancies. Results: In 4 DM1-predicted fetuses with a CTG expansion > 200 CTG, varying numbers of ribonuclear inclusions were clearly visible in all cells. One case with a somatic mosaicism for the DMPK mutation showed 15% of cells with no nuclear foci. No nuclear signals were detected in all controls examined (n = 6) and in 1 DM1-positive sample with a CTG expansion < 100 copies. Conclusion: Nuclear foci, and therefore the DM1 mutation they are caused by, can be detected efficiently on interphase nuclei of trophoblast cells with RNA-FISH when the CTG expansion is > 200 copies. (c) 2006 American Association for Clinical Chemistry

Bonifazi, E., Gullotta, F., Vallo, L., Iraci, R., Nardone, A., Brunetti, E., et al. (2006). Use of RNA fluorescence in situ hybridization in the prenatal molecular diagnosis of myotonic dystrophy type I. CLINICAL CHEMISTRY, 52(2), 319-322 [10.1373/clinchem.2005.056283].

Use of RNA fluorescence in situ hybridization in the prenatal molecular diagnosis of myotonic dystrophy type I

BOTTA, ANNALISA;NOVELLI, GIUSEPPE
2006-01-01

Abstract

Background: Myotonic dystrophy type 1 (DM1; OMIM #160900) is an autosomal-dominant genetic disorder with multisystemic clinical features associated with a CTG expansion in the 3' untranslated region of the DMPK gene on chromosome 19q13.3. A long-PCR protocol to detect the DM1 expansion is rapid, sensitive, and accurate, but interpretative limitations can occur when the expansion size exceeds the PCR amplification range and in cases of somatic mosaicism. Methods: To overcome these problems, we used RNA fluorescence in situ hybridization (RNA-FISH) to study cultured cells derived from chorionic villus samples (CVS) with the DM1 mutation. The RNA-FISH method is designed to detect the distinctive DM1 cellular phenotype, characterized by the presence of nuclei with focal ribonuclear inclusions (foci) containing the DMPK expanded transcripts. We analyzed 6 CVS from DM1-predicted pregnancies and 6 CVS from DM1-negative pregnancies. Results: In 4 DM1-predicted fetuses with a CTG expansion > 200 CTG, varying numbers of ribonuclear inclusions were clearly visible in all cells. One case with a somatic mosaicism for the DMPK mutation showed 15% of cells with no nuclear foci. No nuclear signals were detected in all controls examined (n = 6) and in 1 DM1-positive sample with a CTG expansion < 100 copies. Conclusion: Nuclear foci, and therefore the DM1 mutation they are caused by, can be detected efficiently on interphase nuclei of trophoblast cells with RNA-FISH when the CTG expansion is > 200 copies. (c) 2006 American Association for Clinical Chemistry
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/03 - Genetica Medica
English
Con Impact Factor ISI
myotonic dystrophy protein kinase; RNA; trinucleotide; protein serine threonine kinase; article; autosomal dominant disorder; cell nucleus; chorion villus; controlled study; diagnostic procedure; fetus; fluorescence in situ hybridization; gene mutation; human; human cell; interphase; myotonic dystrophy; phenotype; prenatal diagnosis; trophoblast; female; genetics; metabolism; methodology; mutation; pregnancy; prenatal development; Cell Nucleus; Chorionic Villi; Female; Humans; In Situ Hybridization, Fluorescence; Mutation; Myotonic Dystrophy; Pregnancy; Prenatal Diagnosis; Protein-Serine-Threonine Kinases; RNA
Bonifazi, E., Gullotta, F., Vallo, L., Iraci, R., Nardone, A., Brunetti, E., et al. (2006). Use of RNA fluorescence in situ hybridization in the prenatal molecular diagnosis of myotonic dystrophy type I. CLINICAL CHEMISTRY, 52(2), 319-322 [10.1373/clinchem.2005.056283].
Bonifazi, E; Gullotta, F; Vallo, L; Iraci, R; Nardone, A; Brunetti, E; Botta, A; Novelli, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/29393
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 17
social impact